VJOncology is committed to improving our service to you

ESMO 2017 | The potential of biosimilars in cancer treatment

VJOncology is committed to improving our service to you

Richard Markus

Biosimilars are a promising new addition as a novel treatment option for patients of cancer. Richard Markus, MD, PhD, from Amgen, Los Angeles, CA shares with us his feelings on the attention that biosimilars are gaining from experts in the field, and explains their importance as a new class for cancer treatment. This interview was recorded at the 2017 European Society for Medical Oncology (ESMO) conference held in Madrid, Spain.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter